Age-related cognitive decline, mild cognitive impairment, and progression to other Alzheimer’s Disease-related dementias affects the well-being of older adults, their families and caregivers.
An estimated 5.8 million Americans age 65 and older were living with Alzheimer’s dementia in 2020 with a health care cost estimated at $305 billion.
There are currently no pharmacologic solutions and no other treatments with strong evidence for the prevention of age-related cognitive decline, mild cognitive impairment, or progression to clinical Alzheimer’s-type dementia.